How AI is helping Mexico detect breast cancer earlier

FDA Approves Lilly’s New Oral Combo Pill for Common Breast Cancer Mutation. The Eli Lilly corporate headquarters in Indianapolis, IN, on August 15, 2024. AJ Mast/Bloomberg via Getty Images The FDA approved a new oral combo drug for a common breast cancer mutation on September 18. The treatment includes Inluriyo (imlunestrant) taken with Verzenio (abemaciclib) for adults with ER-positive, HER2-negative advanced or metastatic breast cancer with ESR1 mutation that has spread after hormone therapy. Results from a trial show that among 159 participants with ESR1 mutations, those taking the combination went a median of 11.1 months before their cancer spread,.

Protesters across Spain demand action over housing crisis. More than 50 protests are planned to take place on Saturday after the government failed to get emergency legislation through parliament.

World No 1 Sinner withdraws from Shanghai Masters as knee injury lingers. Italy's Jannik Sinner has not played since Wimbledon win in July, missing US Open and ongoing ATP 500 event in Beijing.

Russia hits second major bridge in Ukraine's capital Kyiv. The strike on the Pivnichnyi (Northern) Bridge comes after repeat attacks on another major bridge in Ukraine's capital.

The double standards of a failed execution. Had Christa Pike faced the death penalty in the Middle East, there would be relentless outrage and condemnations.

Flydubai co-pilot attacked captain with axe, UAE official says. The man accused of trying to take over the Israel-bound jet is named as Hamam al-Hammami by several media outlets.